"Bivalent chromatin as a therapeutic target in cancer: An in silico ..."

Tomás Alarcón et al. (2021)

> Home

Details and statistics

DOI: 10.1371/JOURNAL.PCBI.1008408

access: open

type: Journal Article

metadata version: 2022-01-24

- view
  - electronic edition via DOI (open access)
  authority control:
- export record
  dblp key:
  - journals/ploscb/AlarconSGM21
- ask others
- share record
  persistent URL:
  - https://dblp.org/rec/journals/ploscb/AlarconSGM21
Tomás Alarcón, Josep Sardanyés, Antoni Guillamón, Javier A. Menéndez:
Bivalent chromatin as a therapeutic target in cancer: An in silico predictive approach for combining epigenetic drugs. PLoS Comput. Biol. 17(6) (2021)

manage site settings

To protect your privacy, all features that rely on external API calls from your browser are turned off by default. You need to opt-in for them to become active. All settings here will be stored as cookies with your web browser. For more information see our F.A.Q.